Completed OBSERVATIONAL NCT03391128

Circulating P3NP and Cardiovascular Events in Hemodialysis Patients

Involvement of Circulating Aminoterminal Propeptide of Type 3 Procollagen in Cardiovascular Events in Patients on Hemodialysis

Sponsor: Toujinkai Hospital

Conditions Cardiac Fibrosis Cardiovascular Events

Updated 9 times since 2018 Last updated: Jan 4, 2018 Started: Jan 1, 2005 Primary completion: Jan 31, 2005 Completion: Jan 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiac Fibrosis and Cardiovascular Events and is currently completed. Toujinkai Hospital leads this study, which shows 9 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Jan 2018 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Toujinkai Hospital

Data source: Toujinkai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kyoto, Japan